Trial intelligence / Profile preview

PEG-rhG-CSF versus rhG-CSF after pediatric umbilical cord blood transplantation

ChiCTR2100051086Phase 4Recruiting

Sponsor
Sun Yat-sen Memorial Hospital
Start
Sep 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial in neutropenia comparing PEG-rhG-CSF group with rhG-CSF group (2 arms). Primary endpoint: Neutrophil recovery time. Started Sep 2021; status: recruiting.

02

Drugs

pegfilgrastimNeukast
03

Conditions

neutropenia

Beyond the preview

Go deeper on ChiCTR2100051086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100051086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call